
Loading, please wait...

Loading, please wait...

Modern drug discovery is shifting from the "one drug, one target" model to a more complex understanding of multi-target interactions. Specifically, the PPB3 target prediction tool has emerged as a powerful web-based solution for assessing polypharmacology. By identifying how drug-like molecules interact with multiple biological targets, researchers can better predict both therapeutic potential and unintended side effects.
Furthermore, the PPB3 model utilizes deep neural networks trained on the extensive ChEMBL 34 database. This dataset includes over 1.1 million molecules and roughly 2.5 million interactions. Consequently, the tool covers 7,546 targets, including cell lines and organisms, which were often excluded from previous versions. Therefore, this expanded scope provides a much more comprehensive view of molecular bioactivity than older protein-only models.
Specifically, the tool excels in precision and recall when identifying targets where a molecule is significantly active. Additionally, users can perform these predictions online, making high-level bioinformatics accessible to a broader scientific community. Moreover, understanding these interactions is crucial for drug repurposing efforts in India and globally. Consequently, this technology helps clinicians and researchers identify new uses for existing drugs while minimizing toxicity risks. However, users should always validate computational predictions with experimental data.
The PPB3 tool uses deep learning to predict the biological targets of small molecules, helping researchers understand polypharmacology profiles and potential side effects.
The current version uses ChEMBL 34, containing a much larger dataset of over 7,500 targets, including cell lines and protein complexes, compared to older models limited to single proteins.
Disclaimer: This content is for informational and educational purposes only. It is not intended as medical advice or as a substitute for professional healthcare. Always seek the advice of a qualified health provider regarding any medical condition. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Researchers developed PPB3, a deep learning tool for target prediction and polypharmacology assessment, utilizing a vast dataset of 7,546 targets....
6 months ago

A 2026 meta-analysis evaluates PDE5 inhibitors in advanced ILD with severe gas exchange impairment. While overall mortality was not significantly reduced, a targeted subgroup with pulmonary hypertension showed a 49% risk reduction, underscoring the necessity of precise hemodynamic phenotyping.
Today

At the 79th Regional Committee session, the World Health Organization commended India's public health advancements. Key achievements include the operationalization of 160,000 Ayushman Arogya Mandirs, higher institutional delivery rates, strong ASHA networks, and persistent efforts to eliminate tuberculosis nationwide.
Today

The Supreme Court questioned FSSAI's phased warning approach, urging single-phase implementation for foods exceeding limits in any nutrient of concern. Backed by ICMR-NIN recommendations, the proposed red hexagonal warnings target added sugar, salt, and fat to combat India's escalating chronic disease epidemic.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

A comparative analysis shows that older age, elevated blood glucose, and abdominal adiposity are primary drivers of hypertension. Comprehensive evaluation of cardiometabolic risk profiles enables clinicians to detect overlapping metabolic dysfunctions early and optimize targeted prevention strategies.
Today